Global Prevention of Asthma in Children Study

Phase 2

Recruiting

• Conditions: Allergic Rhinitis; Asthma; Respiratory - Asthma

• Registration Number: ACTRN12607000633482
• Lead Sponsor: ational Institute of Allergy and Infectious Diseases

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-12-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Diagnosed with eczema (atopic dermatitis)
2. Family history of eczema, allergic rhinitis, or asthma
3. Allergy to one or more of the following: egg white, cow’s milk, peanut, or soybean
4. Weigh at least 8.0 kg
5. Parent or guardian willing to provide informed consent

Exclusion Criteria

1. Allergy to house dust mite, cat, or timothy grass
2. Born prematurely (before 36th week's gestation) 3. Previous diagnosis of asthma OR have had 3 or more distinct episodes of wheeze during the first year of life
3. Chronic pulmonary disease
4. Chronic disease requiring therapy
5. Past or current treatment with systemic immunomodulator medication
6. Past or current treatment with allergen-specific immunotherapy
7. Received 10 or more days of systemic steroids in the 3 months prior to study entry
8. Orofacial abnormalities that are likely to interfere with the volunteer's ability to take study treatment
9. Participated in another clinical study within the 3 months prior to study entry

Study & Design

• Study Type: Interventional
• Study Design: Not specified